NOVO NORDISK INC.

DC

Pharmaceutical research, manufacturing and sales.

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 24 of its records are shown together here.

Filings
415
Filed By
24
Reported In-House
$62,485,215
Reported By Firms
$15,845,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2026 WILLIAMS AND JENSEN, PLLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 TODD STRATEGY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 NOVO NORDISK INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$2,010,000
2026 NVG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 THE NICKLES GROUP, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 ARNOLD & PORTER KAYE SCHOLER LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 BALLARD PARTNERS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$120,000
2026 HOLLAND & KNIGHT LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 S-3 GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
Page 1 of 42  ·  415 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings